Atlas Trials

Proof of Mechanism Study of MLN1202 on Atherosclerotic Inflammation in Participants With Stable Atherosclerotic Cardiovascular Disease

Clinical trial NCT02388971 · WITHDRAWN

Trial details

NCT number
NCT02388971
Sponsor
Takeda
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Atherosclerotic Cardiovascular Disease
Start date
2016-04-01
Primary completion
2016-04-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.